A detailed history of Lazard Asset Management LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 33,832 shares of ACAD stock, worth $500,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,832
Previous 26,213 29.07%
Holding current value
$500,375
Previous $484,000 13.43%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$14.62 - $18.42 $111,389 - $140,341
7,619 Added 29.07%
33,832 $549,000
Q1 2024

May 14, 2024

BUY
$17.79 - $30.86 $315,221 - $546,808
17,719 Added 208.61%
26,213 $483,000
Q4 2023

Feb 14, 2024

BUY
$20.78 - $31.77 $44,323 - $67,765
2,133 Added 33.53%
8,494 $265,000
Q3 2023

Nov 14, 2023

BUY
$20.84 - $33.47 $46,598 - $74,838
2,236 Added 54.21%
6,361 $132,000
Q2 2023

Aug 14, 2023

BUY
$17.8 - $25.65 $19,366 - $27,907
1,088 Added 35.82%
4,125 $98,000
Q1 2023

May 15, 2023

BUY
$16.32 - $20.92 $49,563 - $63,534
3,037 New
3,037 $57,000
Q3 2022

Nov 14, 2022

BUY
$14.11 - $18.27 $52,051 - $67,398
3,689 New
3,689 $60,000
Q1 2022

May 13, 2022

SELL
$20.94 - $27.5 $65,228 - $85,662
-3,115 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$16.79 - $27.09 $8,495 - $13,707
506 Added 19.39%
3,115 $72,000
Q3 2021

Nov 15, 2021

BUY
$15.78 - $24.77 $41,170 - $64,624
2,609 New
2,609 $43,000
Q1 2021

May 14, 2021

SELL
$25.02 - $54.99 $33,927 - $74,566
-1,356 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$36.42 - $57.0 $49,385 - $77,292
1,356 New
1,356 $55,000
Q2 2020

Aug 13, 2020

SELL
$39.26 - $52.73 $159,395 - $214,083
-4,060 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$31.65 - $46.87 $1.83 Million - $2.71 Million
-57,786 Reduced 93.44%
4,060 $171,000
Q4 2019

Feb 13, 2020

BUY
$36.21 - $51.4 $2.21 Million - $3.14 Million
61,031 Added 7488.47%
61,846 $2.65 Million
Q3 2019

Nov 14, 2019

BUY
$22.22 - $44.01 $18,109 - $35,868
815 New
815 $29,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.